Prosecution Insights
Last updated: August 18, 2026

Examiner: DAVIS, RUTH A

Tech Center 1600 • Art Units: 1645 1651 1653 1699

This examiner grants 61% of resolved cases

Performance Statistics

60.7%
Allow Rate
+0.7% vs TC avg
950
Total Applications
+31.2%
Interview Lift
1171
Avg Prosecution Days
Based on 906 resolved cases, 2023–2026

Rejection Statute Breakdown

3.7%
§101 Eligibility
15.4%
§102 Novelty
36.6%
§103 Obviousness
27.1%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
19212317 REGULATE GUT MICROBIOTA TO TREAT NEURODEGENERATIVE DISORDERS Non-Final OA California Institute of Technology
18775012 ENGINEERED PROBIOTICS FOR DETECTION OF GASTROINTESTINAL DISEASE IN HUMANS Non-Final OA Northwestern University
18035134 COMPOSITIONS AND METHODS FOR SCREENING PESTICIDES Final Rejection Arizona Board of Regents on Behalf of the University of Arizona
19078488 Methods And Compositions For Increasing Infectivity Of Entomopathogenic Nematodes Non-Final OA PHERONYM INC.
18863229 SPRAY-DRIED PEST CONTROL COMPOSITIONS Non-Final OA Rohm and Haas Company
18917849 GUT BACTERIUM STARIN AND USE THEREOF Non-Final OA SUN YAT-SEN UNIVERSITY
18952409 STABILIZED LIQUID AND LYOPHILIZED ADAMTS13 FORMULATIONS Non-Final OA TAKEDA PHARMACEUTICAL COMPANY LIMITED
18042510 METHOD FOR PRODUCING MODIFIED PROTEIN Final Rejection AMANO ENZYME INC.
18092980 Fruit and Vegetable-Based Fermentate Compositions and Methods of Making and Using the Same Non-Final OA Third Wave Bioactives, LLC
17914309 Method for Evaluating Sample Containing Cell Support-Derived Components Final Rejection Minaris Advanced Therapies Co., Ltd.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month